Sequential analysis as a tool for detection of amikacin ototoxicity in the treatment of multidrug-resistant

Karla Anacleto de Vasconcelos1, Silvana Maria Monte Coelho Frota2, Antonio Ruffino-Netto3

  • 1Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Abstract

Insights

High-frequency audiometry (HFA) and pure-tone audiometry (PTA) effectively detect amikacin-induced ototoxicity in multidrug-resistant tuberculosis (MDR-TB) patients. Distortion-product otoacoustic emission (DPOAE) testing was less efficient for early hearing loss detection.

Area of Science:

  • Ototoxicity research
  • Audiology
  • Tuberculosis treatment monitoring

Background:

  • Amikacin is crucial for multidrug-resistant tuberculosis (MDR-TB) treatment.
  • Amikacin can cause ototoxicity, leading to hearing loss.
  • Early detection of hearing damage is vital for patient management.

Purpose of the Study:

  • To evaluate early detection of amikacin-induced ototoxicity.
  • To compare pure-tone audiometry (PTA), high-frequency audiometry (HFA), and distortion-product otoacoustic emission (DPOAE) testing.
  • To assess hearing changes in MDR-TB patients receiving amikacin.

Main Methods:

  • Longitudinal prospective cohort study.
  • Included 18-69 year old MDR-TB patients receiving amikacin for the first time.
  • Hearing assessed at baseline, 2 months, and 6 months using PTA, HFA, and DPOAE.

Main Results:

  • HFA detected hearing shifts at 2 months; PTA detected shifts at 6 months.
  • DPOAE testing did not detect significant hearing threshold shifts.
  • Sequential analysis refined the final study population to 10 patients.

Conclusions:

  • HFA and PTA are effective for detecting amikacin-associated hearing threshold shifts over six months.
  • DPOAE testing demonstrated limited efficiency in identifying early ototoxicity in this cohort.
  • Monitoring hearing with HFA and PTA is recommended during amikacin treatment for MDR-TB.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Overview of Microsoft Excel as a Data Analysis Tool01:13

Overview of Microsoft Excel as a Data Analysis Tool

Microsoft Excel is a cornerstone tool for data analysis and statistical operations, offering a wide array of functionalities to manage, analyze, and visualize data efficiently. Recognized for its versatility, Excel facilitates the performance of basic to complex statistical operations, serving as an indispensable asset for analysts, researchers, and students alike. Excel's significance in data analysis emanates from its spreadsheet environment, where data can be organized in rows and...
1.6K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
998
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
642
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K